Metagenomic Sequencing Market worth $4.5 Billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=60408643 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=60408643 Browse in-depth TOC on "Metagenomic Sequencing Market"226 - Tables44 - Figures 258 - Pages Metagenomic Sequencing Market Scope: Reagents & Consumables subsegment accounted for the largest share of the metagenomic sequencing market by product & service Among...

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=60408643

Browse in-depth TOC on "Metagenomic Sequencing Market"
226 - Tables
44 - Figures
258 - Pages

Metagenomic Sequencing Market Scope:

Reagents & Consumables subsegment accounted for the largest share of the metagenomic sequencing market by product & service

Among the product & service, the metagenomic sequencing market is segmented reagents & consumables, instruments, sequencing services and analysis & data interpretation solutions. In 2023, the reagents and consumables segment accounted for the largest share of the metagenomic sequencing market by product & service. Growth in this market segment can be attributed to factors such as commercialization of reagents and kits and repetitive purchase of sequencing reagents by demand side entities among others.

Drug discovery is the fastest-growing segment of the metagenomic sequencing market by applications

Among the applications, the metagenomic sequencing market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological & environmental applications, veterinary applications, and other applications. In 2023, the drug discovery segment accounted for the fastest-growing share of the usage segment of metagenomic sequencing market. Growth in this market segment can be attributed to one of the major factors which is the growing number of research activities for development of new drugs.

Europe: The second-largest region in the metagenomic sequencing market.

The European market is the second-largest metagenomic sequencing market globally, mainly due to factors such as increasing number of research projects, especially in the field of soil microbiome metagenomics, in the region. Moreover, Europe is considered a major hub for metagenomic sequencing players and organizations.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=60408643

Metagenomic Sequencing Market Dynamics:

Drivers:

     1.  Continuous technological innovations in NGS platforms

          a.  iSeq 100 System

          b.  Ion GeneStudio S5

     2.  Initiatives and funding from government & private bodies for large-scale sequencing projects

     3.  Declining costs of genome sequencing

     4.  Significant applications of metagenomics in various fields

Restraints:

Opportunities:

Challenges:

Key Market Players:

The market for metagenomic sequencing is consolidated, with key players strategizing to capture the market. Prominent players in the metagenomic sequencing market are Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), and Oxford Nanopore Technologies Plc. (UK) among others.

Recent Developments:

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=60408643

Metagenomic Sequencing Market Advantages:

Overall, metagenomic sequencing's ability to unlock the mysteries of microbial worlds offers a wealth of advantages that will continue to revolutionize multiple fields and lead to groundbreaking discoveries with profound impacts on human health, the environment, and beyond.

Related Reports:

Genomics Market - Global Forecasts to 2028

NGS Sample Preparation Market - Global Forecasts to 2028

Proteomics Market - Global Forecasts to 2028

Next Generation Sequencing Market - Global Forecasts to 2027

Bioinformatics Services Market - Global Forecasts to 2026

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/metagenomic-sequencing-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/metagenomic-sequencing.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/metagenomic-sequencing-market-worth-4-5-billion--marketsandmarkets-301884841.html